Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A novel imaging-based approach for large extracellular vesicle detection and prognostic stratification in metastatic breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer
10.1093/annonc/mdq030 · 2010 · External reference
Large extracellular vesicle characterization and association with circulating tumor cells in metastatic castrate resistant prostate cancer
10.3390/cancers13051056 · 2021 · External reference
Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer
10.1038/s41523-022-00480-4 · 2022 · External reference
Mechanisms and functions of large extracellular vesicle biogenesis
10.1038/s41556-026-01940-w · 2026 · External reference
Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles
10.18632/oncotarget.3598 · 2015 · External reference
Characterizing circulating tumor cells and tumor-derived extracellular vesicles in metastatic castration-naive and castration-resistant prostate cancer patients
10.3390/cancers14184404 · 2022 · External reference
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
10.1186/s13046-019-1317-6 · 2019 · External reference
A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes
10.1016/j.ebiom.2019.01.051 · 2019 · External reference
Single tube liquid biopsy for advanced non‐small cell lung cancer
10.1002/ijc.32056 · 2019 · External reference
Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer
10.1038/s41391-020-00304-1 · 2021 · External reference
Extracellular vesicle heterogeneity through the lens of multiomics
2025 · External reference
HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
10.1186/s13058-020-01323-5 · 2020 · External reference
Tumor-derived extracellular vesicles as complementary prognostic factors to circulating tumor cells in metastatic breast cancer
10.1200/po.22.00372 · 2023 · External reference
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
10.18632/oncotarget.25019 · 2018 · External reference
Phenotypic diversity of CTCs and tdEVs in liquid biopsies of tumour-draining veins is linked to poor prognosis in colorectal cancer
10.1186/s13046-024-03259-6 · 2025 · External reference
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
10.1038/s41416-023-02179-0 · 2023 · External reference
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
10.18632/oncotarget.8250 · 2016 · External reference
The RareCyte platform for next‐generation analysis of circulating tumor cells
10.1002/cyto.a.23619 · 2018 · External reference
Abstract 1147: development of a novel assay to detect circulating tumor cells in the cerebrospinal fluid of patients with leptomeningeal disease
10.1158/1538-7445.am2025-1147 · 2025 · External reference
CTC technologies and tools
10.1002/cyto.a.23684 · 2018 · External reference
Circulating tumor cell detection: a prospective comparison between CellSearch and RareCyte platforms in patients with progressive metastatic breast cancer
10.1007/s10549-022-06585-5 · 2022 · External reference
Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches
10.1002/jev2.12404 · 2024 · External reference
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease
10.1158/0008-5472.can-08-3860 · 2009 · External reference
23P combining circulating tumor cells (CTCs) and tumor-derived extracellular vesical (tdEVs) for prognosis stratification in metastatic breast cancer (mBC)
10.1016/j.esmoop.2025.104577 · 2025 · External reference
Abstract 1968: comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?
10.1158/1538-7445.am2025-1968 · 2025 · External reference
